REGIS HEALTHCARE LIMITED (REG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

REG - REGIS HEALTHCARE LIMITED

FNArena Sector : Aged Care & Seniors
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.05
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.09

20 Dec
2024

-0.290

OPEN

$6.35

-4.55%

HIGH

$6.35

816,022

LOW

$6.03

TARGET
$7.225 18.6% upside
Franking for last dividend paid out: 50%
OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . OCA .
FNARENA'S MARKET CONSENSUS FORECASTS
REG: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx - 7.1 15.7 xxx
DPS (cps) xxx 12.9 15.7 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx 36.3% 21.1% xxx
PE Ratio xxx N/A 38.9 xxx
Dividend Yield xxx N/A 2.6% xxx
Div Pay Ratio(%) xxx N/A 100.0% xxx

Dividend yield today if purchased 3 years ago: 6.95%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.12

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 10/09 - ex-div 6.65c (franking 50%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-7.1
DPS All xxxxxxxxxxxxxxx12.9
Sales/Revenue xxxxxxxxxxxxxxx1,005.8 M
Book Value Per Share xxxxxxxxxxxxxxx-7.6
Net Operating Cash Flow xxxxxxxxxxxxxxx252.3 M
Net Profit Margin xxxxxxxxxxxxxxx-2.13 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-276.16 %
Return on Invested Capital xxxxxxxxxxxxxxx-48.28 %
Return on Assets xxxxxxxxxxxxxxx-1.22 %
Return on Equity xxxxxxxxxxxxxxx-276.16 %
Return on Total Capital xxxxxxxxxxxxxxx-98.47 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx145.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx386 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx65 M
Price To Book Value xxxxxxxxxxxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx65.7 M
Capex % of Sales xxxxxxxxxxxxxxx6.53 %
Cost of Goods Sold xxxxxxxxxxxxxxx967 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx83 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx118 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

27/11/2024

1

Outperform

$7.25

19.05%

Regis Healthcare's trading update at the AGM showed average occupancy of 95.5% in 1Q25, a rise of 60bps from 4Q24, with spot occupancy at 96% as of 31 October 2024, above the company's budget, Macquarie highlights.

Average government revenue per occupied bed day rose to $299.30 in 1Q25, stable compared to 4Q24, with the analyst forecasting $309 in 1H25.

Macquarie lifts FY25 EPS forecast by 1%, reflecting slight changes to occupancy assumptions. The company is seen as well-positioned with net cash of $64.9m and positive organic growth.

Target price rises to $7.25 from $6.50. Outperform rating retained.

FORECAST
Macquarie forecasts a full year FY25 dividend of 14.50 cents and EPS of 14.50 cents.
Macquarie forecasts a full year FY26 dividend of 18.60 cents and EPS of 18.60 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

16/09/2024

2

Overweight

$4.46

-26.77%

Jarden notes the Federal Government's Aged Care reform will take two and a half years to have a full financial impact on companies like Regis Healthcare.

The analyst estimates $27.5m in additional income per annum for the company which will be forthcoming in FY28/FY29 or an 18% rise to EBITDA over this period compared to current forecasts.

There are no changes to the broker's earnings forecasts.

Overweight rating and $4.46 target price remain.

FORECAST
Jarden forecasts a full year FY25 dividend of 4.00 cents and EPS of 19.60 cents.
Jarden forecasts a full year FY26 dividend of 6.00 cents and EPS of 22.40 cents.

REG STOCK CHART